Raleigh Capital Management’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Raleigh Capital Management's JNJ Position: Q2 2026 in Review
Raleigh Capital Management reduced its Johnson & Johnson (JNJ) stake by 0.69% in Q2 2026, selling an estimated $6.06K and leaving 3,730 shares worth $947K. The position accounts for 0.3% of the portfolio, ranked #88.
Raleigh Capital Management first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.96M in Q3 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Raleigh Capital Management held 3,730 shares of Johnson & Johnson worth $947K as of Q2 2026.
- Raleigh Capital Management sold 26 Johnson & Johnson shares in Q2 2026, an estimated $6.06K.
- Johnson & Johnson made up 0.3% of Raleigh Capital Management's portfolio in Q2 2026, its #88 holding.
- Raleigh Capital Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
- Raleigh Capital Management's Johnson & Johnson position peaked at $2.96M in Q3 2025.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.